GRAIL, Inc. (GRAL)
GRAIL, Inc. (GRAL) is a healthcare company (diagnostics & research) based in the United States. The share price is $104.29, down 1.25% on the day, which values the company at $4.69B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.
Key facts
- Share price
- $104.29−1.25% today
- Market value
- $4.69B
- Funk Score
- 64/100
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
GRAIL, Inc. in more detail
GRAL trades at -12.8× next year's expected earnings, 28.1× sales.
Its Funk Score is 64 out of 100 (financial strength 7.2, profitability 2.0, growth 10.0, each out of 10).
In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Heavy stock-based pay.
3 of the superinvestors tracked here hold GRAL, including Andrew Spokes (3.0% of the portfolio), Julian and Felix Baker (1.4% of the portfolio), Primecap team (0.2% of the portfolio).
Superinvestors holding GRAL
3 of the investors tracked here report a position in their latest 13F filing.
- Andrew Spokes Farallon Capital Management2.97% of portfolio · $570.2M · trimmed · Q3 2026
- Julian and Felix Baker Baker Bros. Advisors1.38% of portfolio · $275M · Q2 2026
- Primecap team Primecap Management0.19% of portfolio · $311.2M · added · Q3 2026
Health Care companies of similar size
- Ligand PharmaceuticalsLGND
- Scholar Rock HoldingSRRK
- TeleflexTFX
- Mirum PharmaceuticalsMIRM
- VeradermicsMANE
- GrifolsGRFS
- Cogent BiosciencesCOGT
- LifeStance Health GroupLFST
- BillionToOneBLLN
- Hims & Hers HealthHIMS
- PTC TherapeuticsPTCT
- HaemoneticsHAE
Side by side:GRAL vs COGT (GRAIL, Inc. vs Cogent Biosciences)GRAL vs GRFS (GRAIL, Inc. vs Grifols)GRAL vs MANE (GRAIL, Inc. vs Veradermics)GRAL vs LFST (GRAIL, Inc. vs LifeStance Health Group)GRAL vs MIRM (GRAIL, Inc. vs Mirum Pharmaceuticals)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
GRAIL, Inc. (GRAL): questions and answers
What is GRAIL, Inc.'s market cap?
GRAIL, Inc. is valued at $4.69B at a share price of $104.29.
How fast is GRAIL, Inc. growing?
Over the last three fiscal years GRAIL, Inc.'s revenue grew 38.4% a year.
Does GRAL pay a dividend?
GRAIL, Inc. does not currently pay a regular dividend.
Which famous investors own GRAL?
In their latest quarterly filings, Andrew Spokes (3.0% of the portfolio), Julian and Felix Baker (1.4% of the portfolio), Primecap team (0.2% of the portfolio) hold GRAL. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “GRAIL, Inc. (GRAL) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/GRAL
Underlying data: Yahoo Finance; company filings with the SEC.